Literature DB >> 24293242

Clinical evaluation of mtp40 polymerase chain reaction for the diagnosis of extra pulmonary tuberculosis.

Maruthai Kathirvel1, Vallayyachari Kommoju, Usharani Brammacharry, Thirumurugan Ravibalan, Nandikolla Ravishankar, Balu Radhakrishnan, Muthuraj Muthaiah.   

Abstract

Rapid and sensitive detection of Mycobacterium tuberculosis from patient samples is vital for clinical diagnosis and treatment. The emergence of M. tuberculosis strains with either no copies or only a single copy of IS6110 in Asian countries makes the standard PCR based diagnosis of M. tuberculosis using IS6110 not reliable. We studied the diagnostic efficacy of the in-house PCR amplification of the candidate gene mtp40 as an alternative to IS6110 element based diagnosis. Clinical samples included pulmonary and extra-pulmonary specimens from TB suspected patients residing in Puducherry, South India and were analyzed using in-house PCR procedures targeting IS6110 element and mtp40 genes. Out of 317 clinical specimens analyzed, 132 (41.6 %) and 114 (36 %) were found positive for mtp40 PCR and IS6110 PCR, respectively. However, 18 specimens that were found to negative for IS6110 PCR were found positive for mtp40 PCR, which was further confirmed by DNA sequencing method. PCR amplification of mtp40 gene for the diagnosis of M. tuberculosis in clinical samples is fast, sensitive, and further identified clinical strains that lack IS6110 element in this region. It is clearly demonstrated that there is a significant difference between the two PCR procedures and the sensitivity and specificity levels of mtp40 PCR were found to be higher when compared with DNA sequencing method. Thus, mtp40 based PCR technique will be beneficial in diagnosis of TB where M. tuberculosis strains lack of IS6110 element is predominant.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24293242     DOI: 10.1007/s11274-013-1566-z

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  18 in total

1.  Implications of low frequency of IS6110 in fingerprinting field isolates of Mycobacterium tuberculosis from Kerala, India.

Authors:  I Radhakrishnan; M Y K; R A Kumar; S Mundayoor
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis.

Authors:  M Caws; S M Wilson; C Clough; F Drobniewski
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Evaluation of mtp40 genomic fragment amplification for specific detection of Mycobacterium tuberculosis in clinical specimens.

Authors:  E A Herrera; M Segovia
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe.

Authors:  R Sahadevan; S Narayanan; C N Paramasivan; R Prabhakar; P R Narayanan
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

5.  Analysis of genetic polymorphisms affecting the four phospholipase C (plc) genes in Mycobacterium tuberculosis complex clinical isolates.

Authors:  C Viana-Niero; P E de Haas; D van Soolingen; S C Leão
Journal:  Microbiology       Date:  2004-04       Impact factor: 2.777

6.  Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.

Authors:  Muthuraj Muthaiah; Sridharan Jagadeesan; Nisha Ayalusamy; Manupriya Sreenivasan; Sambamurthy Sangamesvara Prabhu; Usharani Muthuraj; Kamatchiyammal Senthilkumar; Saroja Veerappan
Journal:  Int J Mol Sci       Date:  2010-07-07       Impact factor: 5.923

7.  Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis.

Authors:  S M Wilson; R McNerney; P M Nye; P D Godfrey-Faussett; N G Stoker; A Voller
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

8.  IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India.

Authors:  S Das; C N Paramasivan; D B Lowrie; R Prabhakar; P R Narayanan
Journal:  Tuber Lung Dis       Date:  1995-12

9.  DNA fingerprinting of Mycobacterium tuberculosis isolates from Agra region by IS 6110 probe.

Authors:  A Chauhan; D S Chauhan; D Parashar; P Gupta; V D Sharma; A S Sachan; R Gupta; B M Agarawal; V M Katoch
Journal:  Indian J Med Microbiol       Date:  2004 Oct-Dec       Impact factor: 0.985

10.  Diagnosis and species identification of mycobacterial infections by polymerase chain reaction-restriction fragment length polymorphism analysis of sterile body fluids.

Authors:  Cheong Ho Cho; Sang Hoon Han; Bum Sik Chin; Suk Hoon Choi; Han Sung Lee; Chang Oh Kim; Myung Soo Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Korean J Intern Med       Date:  2009-06-08       Impact factor: 2.884

View more
  3 in total

1.  Performance of nested multiplex PCR assay targeting MTP40 and IS6110 gene sequences for the diagnosis of tubercular lymphadenitis.

Authors:  Pallavi Sinha; Pradyot Prakash; Shashikant C U Patne; Shampa Anupurba; Sweety Gupta; G N Srivastava
Journal:  J Microbiol       Date:  2016-12-30       Impact factor: 3.422

2.  Differentiation of Mycobacterium tuberculosis complex from non-tubercular mycobacteria by nested multiplex PCR targeting IS6110, MTP40 and 32kD alpha antigen encoding gene fragments.

Authors:  Pallavi Sinha; Anamika Gupta; Pradyot Prakash; Shampa Anupurba; Rajneesh Tripathi; G N Srivastava
Journal:  BMC Infect Dis       Date:  2016-03-12       Impact factor: 3.090

3.  The Effects of Serum hs-CRP on the Incidence of Lung Cancer in Male Patients with Pulmonary Tuberculosis.

Authors:  Youhua Jiang; Kewei Ni; Meiyu Fang; Junling Li
Journal:  Iran J Public Health       Date:  2019-07       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.